Final Program

WEDNESDAY • MAY 18 363
P73
P74
P75
P76
Facilitator:
P77
P78
P79
P80
P81
P82
D38
Inhibition of Soluble Epoxide Hydrolase Does Not Augment
Hypoxic Pulmonary Vasoconstriction in Healthy Subjects/A.
Lazaar, A. Baines, M. Ahmed, R. Boardley, A. Hussaini, King of
Prussia, PA, p.A6840
Narrow Spectrum Kinase Inhibitors: The Efficacy of a Novel
Class of Inhaled Anti-Inflammatory Molecules in Chronic
Obstructive Pulmonary Disease (COPD) Patients/P. Russell, C.
Charron, C. Robinson, K. Xia, T. Kosoglou, L. O’Dowd, L. Cass, G.
Dines, A. Brindley, C. Stevenson, London, United Kingdom, p.A6841
Safety and Efficacy of AQX-1125 in Chronic Obstructive
Pulmonary Disease (COPD) - Results of the Phase 2 Flagship
Study/D. Scholl, J. Vestbo, P. Tam, L. Mackenzie, C. Harwig, J.
Toews, S. Shrewsbury, Vancouver, Canada, p.A6842
A 12 Week, Randomized, Double-Blind, Placebo Controlled
Study of the Efficacy of RV568 (JNJ49095397), a Narrow
Spectrum Kinase Inhibitor, in COPD Patients/C. Robinson, K.
Xia, P. Russell, C. Stevenson, M. Loza, T. Kosoglou, A. Brindley, F.
Baribaud, P. Silkoff, E. Barnathan, L. O’Dowd, G. Dines, Spring
House, PA, p.A6843
S.A. Christenson, MD, San Francisco, CA
A Novel COPD Exacerbation Trial Design/M. Fageras, B.J.
Make, N. Patel, P.M. Calverley, Molndal, Sweden, p.A6844
Safety, Tolerability and Pharmacokinetic Profile of CHF6001, a
Novel Selective Inhaled PDE4 Inhibitor, in Healthy
Volunteers/M.-A. Nandeuil, F. Mariotti, G. Lucci, D. Santoro, G.
Poli, D. Acerbi, Courbevoie Cedex, France, p.A6845
Genes or Dose, East or West What Makes N Acetyl Cysteine
Work? Meta-Analysis of NAC Low Dose Vs High Dose
Comparing Trials Done in Asian Population Vs European
Population /S.U. Rehman, T. Vacek, A. Ali, Y. Alahwal, N.S.
Khan, A. Kubbara, N. Kozodoi, A. Flora, S. Khudder, J.
Hammersely, D. Olson, Toledo, OH, p.A6846
Too Much or Not Enough? Natural Products for Chronic
Obstructive Pulmonary Disease (COPD) and Asthma/J. Shergis, L.
Wu, A. Zhang, X. Guo, C. Lu, C. Xue, Bundoora, Australia, p.A6847
Effects of Carbocysteine Lysine Salt in Patients with COPD/D.
Lacedonia, G. Patricelli, G.E. Carpagnano, M.P. Foschino Barbaro,
Foggia, Italy, p.A6848
Frequency of Exacerbations in Chronic Obstructive Pulmonary
Disease: The Efficacy of Carbocysteine Lysine Salt with or
Without Inhaled Steroids/G. Paone, L. Lanata, F. Saibene, R.
Delli Colli, B. Moscatelli, G. Puglisi, Rome, Italy, p.A6849
THEMATIC POSTER SESSION
COPD: PHYSIOLOGIC EVALUATION
9:00 a.m. - 3:30 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area A, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P84
P85
P86
P87
P88
P89
P90
P91
P92
P93
Facilitator:
P94
F.C. Sciurba, MD, Pittsburgh, PA
A Comparison Between the Metronome-Paced Tachypnea Test
and Cardiopulmonary Exercise Testing in Detecting Dynamic
Hyperinflation in an Average COPD Population/E. Vis, A.
Hoekstra - Kuik, N. Veeger, A. Ten Brinke, J. Van Der Maten,
Leeuwarden, Netherlands, p.A6850
Second Order Transfer Function of Specific Resistance Loops
to Detect Presence of COPD/M. Topalovic, R. Zonanashvili, V.
Exadaktylos, D. Berckmans, J.-M. Aerts, T. Troosters, W.
Janssens, Leuven, Belgium, p.A6851
The Effect of Lung Cancer Resection on Chest Wall Mechanics
of COPD Patients/G. Elshafie, A. Aliverti, P. Kumar, R. Steyn, M.
Kalkat, E. Bishay, P. Rajesh, B. Naidu, Birmingham, United
Kingdom, p.A6852
The Inverse Relationship Between Volume and Expiratory Flow
Identifies Chronic Obstructive Pulmonary Disease/A. Oh, T.A.
Morris, I.T. Yoshii, T. Morris, San Diego, CA, p.A6853
Oscillometry Small Airways Phenotypes Are Predictive of
GOLD Classification, Lung Function and Emphysema but Not
Chronic Bronchitis in Community Practice COPD/R.J.
Dandurand, M. Dandurand, R.S.J. Estepar, J. Bourbeau, D.H.
Eidelman, Montreal, Canada, p.A6854
Residual Volume Responsiveness to Bronchodilators Over
Time/C. Sutton, C. McCartney, S.K. Patolia, S. Naydenov, R.
Nayak, St. Louis, MO, p.A6855
Daily Peak Expiratory Flow Rate Measured at Home Reflects
Laboratory Measurement of Peak Expiratory Flow Rate in
Chronic Obstructive Pulmonary Disease (COPD)/R.N. Criner,
K.M. Criner, A.J. Criner, N. Marchetti, F. Jaffe, M.J. Markus, S.L.
Krachman, A. Rastogi, H.S. Smith, G.J. Criner, Philadelphia, PA,
p.A6856
Influenza Vaccination in COPD Patients - No Detectable
Changes in Lung Function, Systemic or Airway Inflammatory
Markers/G.C. Donaldson, B. Kowlessar, R. Sapsford, A.R.C. Patel,
A.J. Mackay, R. Singh, J.A. Wedzicha, United Kingdom, p.A6857
Effects of Age, Gender, Race, and Degree of Baseline Airflow
Obstruction on Daily Peak Expiratory Flow Rate (PEFR)
Variability in Moderate to Severe COPD/K.M. Criner, R.N. Criner,
A.J. Criner, H.S. Smith, D. Yu, N. Marchetti, F. Jaffe, S.L.
Krachman, A. Rastogi, M.J. Markus, G.J. Criner, Philadelphia, PA,
p.A6858
Exercise Ventilatory Mechanics by Optoelectronic
Plethysmography Before and After Lung Volume Reduction
Surgery: A Case Series/A.M. Layton, B.M. Thomashow, J.
Guenette, W. Bulman, P.A. Jellen, B.A. Whippo, A.D. Ramlogan, M.
Ginsburg, New York, NY, p.A6859
C. Bime, MD, Tucson, AZ
Efficacy and Safety of Novel 4-Grade Devices for Simulation
Experience of Effort Breathing in Healthy Subjects/Y.
Tokunaga, T. Kawayama, T. Kinoshita, H. Oda, A. Yorita, H.
Imaoka, T. Hoshino, Japan, p.A6860
WEDNESDAY MORNING
ATS 2016 • San Francisco